Recombinant Proteins
Product List
VTN Human
Vitronectin Human Recombinant
CFB (260-764) Human, Sf9
Complement Factor B (260-764 a.a.) Human Recombinant, Sf9
VTN Human, Sf9
Vitronectin Human Recombinant, Sf9
Produced in Sf9 insect cells, VTN is a single, glycosylated polypeptide chain comprising 468 amino acids (20-478a.a.). It has a molecular mass of 53.3 kDa. On SDS-PAGE, the molecular size appears approximately between 50-70 kDa.
This VTN protein is expressed with a 9 amino acid His tag at the C-terminus and purified using proprietary chromatographic techniques.
Sf9, Insect cells.
CFLAR Human
CASP8 and FADD-Like Apoptosis Regulator Human Recombinant
CKS1B Human
CDC28 Protein Kinase Regulatory Subunit 1B Human Recombinant
Introduction
The term “Other” can be defined in various contexts. In a general sense, it refers to something or someone that is different or distinct from the one already mentioned or known . In biological taxonomy, classification involves organizing living organisms into hierarchical categories based on their characteristics and evolutionary history .
Biological properties of “Other” can be understood through key characteristics shared by living organisms, such as order, sensitivity or response to stimuli, reproduction, growth and development, regulation, homeostasis, and energy processing . These properties are expressed in various patterns and distributed across different tissues, contributing to the organism’s overall function and survival.
The primary biological functions of “Other” include catalyzing chemical reactions, synthesizing and repairing DNA, transporting materials across cells, receiving and sending chemical signals, responding to stimuli, and providing structural support . These functions play crucial roles in immune responses and pathogen recognition, ensuring the organism’s defense mechanisms are active and effective .
Modes of action describe the functional or anatomical changes resulting from exposure to a substance. This includes the interaction with other molecules and cells, binding partners, and downstream signaling cascades . For example, a mode of action could involve binding to DNA, leading to transcriptional regulation .
Regulatory mechanisms control the expression and activity of “Other” through transcriptional regulation and post-translational modifications . These mechanisms ensure that the biological processes are carried out efficiently and accurately, adapting to the organism’s needs and environmental changes.
In biomedical research, “Other” has various applications, including diagnostic tools and therapeutic strategies . For instance, understanding the biological properties and functions of different molecules can lead to the development of new treatments and diagnostic methods, improving healthcare outcomes.
